Patent Assignment
Reel/Frame 035924/0004
Assignment of Assignor's Interest
Recorded: 2015-06-16
Pages: 17
Assignor
INCYTE CORPORATION
Executed: 2015-01-07
Assignee
INCYTE HOLDINGS CORPORATION AND INCYTE CORPORATION
1801 AUGUSTINE CUT-OFF, WILMINGTON, DELAWARE, 19803
Covered Properties
(119)
1,2,5-Oxadiazoles as Inhibitors of Indoleamine 2,3-Dioxygenase
Application:
61/078,876 →
1,2,5-Oxadiazoles as Inhibitors of Indoleamine 2,3-Dioxygenase
Application:
61/150,873 →
Process for the Synthesis of an Indoleamine 2,3-Dioxygenase Inhibitor
Application:
61/901,689 →
N-(Hetero)Aryl-Pyrrolidine Derivatives of Pyrazol-4-Yl-Pyrrolo[2,3-D]Pyrimidines and Pyrrol-3-Yl-Pyrrolo[2,3-D]Pyrimidines as Janus Kinase Inhibitors
N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
HETEROCYCLIC DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
Piperidin-4-Yl Azetidine Derivatives as JAK1 Inhibitors
Piperidin-4-Yl Azetidine Derivatives as JAK1 Inhibitors
Cyclobutyl Substituted Pyrrolopyridine and Pyrrolopyrimidine Derivatives as Jak Inhibitors
Heterocyclic-Substituted Pyrrolopyridines and Pyrrolopyrimidines as Jak Inhibitors
Azetidinyl Phenyl, Pyridyl or Pyrazinyl Carboxamide Derivatives as Jak Inhibitors
Azetidinyl Phenyl, Pyridyl or Pyrazinyl Carboxamide Derivatives as Jak Inhibitors
Processes and Intermediates for Making a Jak Inhibitor
Cyclohexyl Azetidine Derivatives as Jak Inhibitors
Processes and Intermediates for Making a Jak Inhibitor
Piperidinylcyclobutyl Substituted Pyrrolopyridine and Pyrrolopyrimidine Derivatives as Jak Inhibitors
Tricyclic Fused Thiophene Derivatives as Jak Inhibitors
N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
Application:
61/180,622 →
N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
Application:
61/225,092 →
HETEROCYCLIC DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
Application:
61/238,794 →
Piperidin-4-Yl Azetidine Derivatives as JAK1 Inhibitors
Application:
61/312,588 →
Piperidin-4-Yl Azetidine Derivatives as JAK1 Inhibitors
Application:
61/415,602 →
Cyclobutyl Substituted Pyrrolopyridine and Pyrrolopyrimidines Derivatives as Jak Inhibitors
Application:
61/415,705 →
Heterocyclic-Substituted Pyrrolopyridines and Pyrrolopyrimidines as Jak Inhibitors
Application:
61/415,617 →
Azetidinyl Phenyl, Pyridyl or Pyrazinyl Carboxamide Derivatives as Jak Inhibitors
Application:
61/498,942 →
Azetidinyl Phenyl, Pyridyl or Pyrazinyl Carboxamide Derivatives as Jak Inhibitors
Application:
61/591,094 →
Processes and Intermediates for Making a Jak Inhibitor
Application:
61/531,896 →
Cyclohexyl Azetidine Derivatives as JAK Inhibitors
Application:
61/525,081 →
Cyclohexyl Azetidine Derivatives as JAK Inhibitors
Application:
61/674,694 →
Processes and Intermediates for Making a Jak Inhibitor
Application:
61/773,659 →
Piperidinylcyclobutyl Substituted Pyrrolopyridine and Pyrrolopyrimidine Derivatives as Jak Inhibitors
Application:
61/648,869 →
Tricyclic Fused Thiophene Derivatives as Jak Inhibitors
Application:
61/721,308 →
Tricyclic Fused Thiophene Derivatives as Jak Inhibitors
Application:
61/783,850 →
Pyrrolo[2,3-B]Pyridin-4-Yl-Amines and Pyrrolo[2,3-B]Pyrimidin-4-Yl-Amines as Janus Kinase Inhibitors
Pyrrolo[2,3-B]Pyridin-4-Yl-Amines and Pyrrolo[2,3-B]Pyrimidin-5-Yl-Amines as Janus Kinase Inhibitors
Pyrrolo[2,3-B]Pyridin-4-Yl-Amines and Pyrrolo[2,3-B]Pyrimidin-5-Yl-Amines as Janus Kinase Inhibitors
PYRROLO[2,3-b]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-b]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS
PYRROLO[2,3-b]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-b]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS
Azepine Inhibitors of Janus Kinases
Azepine Inhibitors of Janus Kinases
Heteroaryl Substituted Pyrrolo[2,3-B]Pyridines and Pyrrolo[2,3-B]Pyrimidines as Janus Kinase Inhibitors
Heteroaryl Substituted Pyrrolo[2,3-B]Pyridines and Pyrrolo[2,3-B]Pyrimidines as Janus Kinase Inhibitors
HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS
Heteroaryl Substituted Pyrrolo[2,3-B]Pyridines and Pyrrolo[2,3-B]Pyrimidines as Janus Kinase Inhibitors
Heteroaryl Substituted Pyrrolo[2,3-B] Pyridines And Pyrrolo[2,3-B] Pyrimidines As Janus Kinase Inhibitors
Heteroaryl Substituted Pyrrolo[2,3-B]Pyridines And Pyrrolo[2,3-B]Pyrimidines As Janus Kinase Inhibitors
Heteroaryl Substituted Pyrrolo[2,3-B] Pyridines And Pyrrolo[2,3-B] Pyrimidines As Janus Kinase Inhibitors
PYRAZOLYL SUBSTITUTED PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS
HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS
Application:
13/754,533 →
Publication:
US 2013/0137681
Substituted Heterocycles as Janus Kinase Inhibitors
Substituted Heterocycles as Janus Kinase Inhibitors
Topical Formulation for a Jak Inhibitor
Application:
13/112,370 →
Publication:
US 2011/0288107
Metabolites of the Janus Kinase Inhibitor (R)-3-(4-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-1H-Pyrazol-1-Yl)-3-Cyclopentylpropanenitrile
METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE
METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE
Application:
14/518,419 →
Publication:
US 2015/0164900
Salts of the Janus Kinase Inhibitor (R)-3-(4-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-1H-Pyrazol-1-Yl)-3-Cyclopentylpropanenitrile
Salts of the Janus Kinase Inhibitor (R)-3-(4-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-1H-Pyrazol-1-Yl)-3-Cyclopentylpropanenitrile
Application:
14/097,598 →
Publication:
US 2014/0094477
Salts of the Janus Kinase Inhibitor (R)-3-(4-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-1H-Pyrazol-1-Yl)-3-Cyclopentylpropanenitrile
Patent:
8,822,481 →
Application:
14/256,383 →
Salts of the Janus Kinase Inhibitor (R)-3-(4-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-1H-Pyrazol-1-Yl)-3-Cyclopentylpropanenitrile
Patent:
8,829,013 →
Application:
14/256,311 →
Salts of the Janus Kinase Inhibitor (R)-3-(4-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-1H-Pyrazol-1-Yl)-3-Cyclopentylpropanenitrile
4-Pyrazolyl-N-Arylpyrimidin-2-Amines and 4-Pyrazolyl-N-Heteroarylpyrimidin-2-Amines as Janus Kinase Inhibitors
Azetidine and Cyclobutane Derivatives as Jak Inhibitors
Azetidine and Cyclobutane Derivatives as Jak Inhibitors
Azetidine and Cyclobutane Derivatives as Jak Inhibitors
Application:
13/853,475 →
Publication:
US 2013/0225556
Processes for Preparing Jak Inhibitors and Related Intermediate Compounds
Processes for Preparing Jak Inhibitors and Related Intermediate Compounds
Processes for Preparing Jak Inhibitors and Related Intermediate Compounds
Processes for Preparing Jak Inhibitors and Related Intermediate Compounds
Janus Kinase Inhibitors for Treatment of Dry Eye and Other Eye Related Diseases
Application:
13/564,271 →
Publication:
US 2012/0301464
3-[4-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-1H-Pyrazol-1-Yl]Octane- or Heptane-Nitrile as Jak Inhibitors
3-[4-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-1H-Pyrazol-1-Yl]Octane- or Heptane-Nitrile as Jak Inhibitors
Hydroxyl, Keto, and Glucuronide Derivatives of 3-(4-(7H-Pyrrolo[2,3-D] Pyrimidin-4-Yl)-1H-Pyrazol-1-Yl)-3-Cyclopentylpropanenitrile
HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE
Hydroxyl, Keto, and Glucuronide Derivatives of 3-(4-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-1H-Pyrazol-1-Yl)-3-Cyclopentylpropanenitrile
Cyclobutane and Methylcyclobutane Derivatives as Janus Kinase Inhibitors
Application:
13/030,682 →
Publication:
US 2011/0207754
Cyclobutane and Methylcyclobutane Derivatives as Janus Kinase Inhibitors
Application:
14/499,916 →
Publication:
US 2015/0087662
Sustained-Release Dosage Forms of Ruxolitinib
Pyrrolo[2,3-b]pyridin-4-yl-amines as janus kinase inhibitors, compositions thereof and methods of using the same
Application:
60/638,474 →
Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidinyl-amines as janus kinase inhibitors
Application:
60/726,289 →
Tetracyclic inhibitors of janus kinases
Application:
60/719,462 →
Azepine inhibitors of janus kinases
Application:
60/810,490 →
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
Application:
60/749,905 →
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
Application:
60/810,231 →
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3,-b]pyrimidines as janus kinase inhibitors
Application:
60/850,625 →
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyridines as Janus kinase inhibitors
Application:
60/856,872 →
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
Application:
60/859,404 →
Substituted heterocycles as janus kinase inhibitors
Application:
60/876,705 →
Substituted heterocycles as janus kinase inhibitors
Application:
60/928,205 →
Topical Formulation for a Jak Inhibitor
Application:
61/347,132 →
METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE
Application:
60/943,695 →
SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3- CYCLOPENTYLPROPANENITRILE
Application:
60/943,705 →
4-Pyrazolyl-N-Arylpyrimidin-2-Amines and 4-Pyrazolyl-N-Heteroarylpyrimidin-2-Amines as Janus Kinase Inhibitors
Application:
60/988,606 →
Azetidine and Cyclobutane Derivatives as Jak Inhibitors
Application:
61/035,662 →
Azetidine and Cyclobutane Derivatives as Jak Inhibitors
Application:
61/144,982 →
Processes for Preparing Jak Inhibitors and Related Intermediate Compounds
Application:
61/144,991 →
Janus Kinase Inhibitors for Treatment of Dry Eye and Other Eye Related Diseases
Application:
61/102,242 →
3-[4-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-1H-Pyrazol-1-Yl]Octanenitrile as Jak Inhibitor
Application:
61/180,582 →
HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1YL)-3-CYCLOPENTYLPROPANENITRILE
Application:
61/250,387 →
HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE
Application:
61/316,218 →
Cyclobutane and Methylcyclobutane Derivatives as Janus Kinase Inhibitors
Application:
61/305,630 →
Sustained-Release Dosage Forms of Ruxolitinib
Application:
61/726,893 →
Sustained-Release Dosage Forms of Ruxolitinib
Application:
61/769,408 →
Pyrimidinones as PI3K Inhibitors
Pyrimidinones as PI3K Inhibitors
Substituted Heteroaryl Fused Derivatives as PI3K Inhibitors
Substituted Heteroaryl Fused Derivatives as PI3K Inhibitors
Substituted Fused Aryl and Heteroaryl Derivatives as PI3K Inhibitors
Fused Pyrrole Derivatives as PI3K Inhibitors
Fused Derivatives as PI3KDELTA Inhibitors
N-(1-(Substituted-Phenyl)Ethyl)-9H-Purin-6-Amines as PI3K Inhibitors
Substituted Diamino-Pyrimidine and Diamino-Pyridine Derivatives as PI3K Inhibitors
Pyrimidine-4,6-Diamine Derivatives as PI3K Inhibitors
Heterocyclylamines as PI3K Inhibitors
Bicyclic Azaheterocyclobenzylamines as PI3K Inhibitors
Use of Pyrazolopyrimidine Derivatives for the Treatment of PI3K-Delta Related Disorders
Pyrimidinones as PI3K Inhibitors
Application:
61/221,160 →
Pyrimidinones as PI3K Inhibitors
Application:
61/259,765 →
Substituted Heteroaryl Fused Derivatives as PI3K Inhibitors
Application:
61/287,893 →
Substituted Fused Aryl and Heteroaryl Derivatives as PI3K Inhibitors
Application:
61/287,904 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 15, 2008
From: COMBS, ANDREW P.; YUE, EDDY W.; SPARKS, RICHARD B.; ZHU, WENYU
To: INCYTE CORPORATION
Reel/Frame 021982/0748 →
Assignment of Assignor's Interest
Apr 15, 2009
From: COMBS, ANDREW P.; YUE, EDDY W.; SPARKS, RICHARD B.; ZHU, WENYU
To: INCYTE CORPORATION
Reel/Frame 022540/0330 →
Assignment of Assignor's Interest
Jun 24, 2009
From: RODGERS, JAMES D.; SHEPARD, STACEY; ARVANITIS, ARGYRIOS G.; WANG, HAISHENG
To: INCYTE CORPORATION
Reel/Frame 022870/0582 →
Assignment of Assignor's Interest
Sep 4, 2009
From: RODGERS, JAMES D.; SHEPARD, STACEY; ARVANITIS, ARGYRIOS G.; WANG, HAISHENG
To: INCYTE CORPORATION
Reel/Frame 023194/0089 →
Assignment of Assignor's Interest
Apr 21, 2010
From: HUANG, TAISHENG; XUE, CHU-BIAO; WANG, ANLAI; KONG, LING
To: INCYTE CORPORATION
Reel/Frame 024265/0711 →
Assignment of Assignor's Interest
May 12, 2010
From: RODGERS, JAMES D.; LI, YUN-LONG
To: INCYTE CORPORATION
Reel/Frame 024374/0189 →
Assignment of Assignor's Interest
Jul 22, 2010
From: RODGERS, JAMES D.; SHEPARD, STACEY; ARVANITIS, ARGYRIOS G.; WANG, HAISHENG
To: INCYTE CORPORATION
Reel/Frame 024725/0213 →
Assignment of Assignor's Interest
Aug 31, 2010
From: SHEPARD, STACEY
To: INCYTE CORPORATION
Reel/Frame 024914/0607 →
Assignment of Assignor's Interest
Dec 2, 2010
From: RODGERS, JAMES D.; LI, YUN-LONG; SHEPARD, STACEY; WANG, HAISHENG
To: INCYTE CORPORATION
Reel/Frame 025436/0796 →
Assignment of Assignor's Interest
Dec 13, 2010
From: HUANG, TAISHENG; XUE, CHU-BIAO; WANG, ANLAI; KONG, LING QUAN
To: INCYTE CORPORATION
Reel/Frame 025475/0455 →
Assignment of Assignor's Interest
Mar 4, 2011
From: RODGERS, JAMES D.; LI, HUI-YIN; LI, QUN
To: INCYTE CORPORATION
Reel/Frame 025902/0351 →
Assignment of Assignor's Interest
Mar 4, 2011
From: RODGERS, JAMES D.
To: INCYTE CORPORATION
Reel/Frame 025902/0367 →
Assignment of Assignor's Interest
Jun 17, 2011
From: HUANG, TAISHENG; XUE, CHU-BIAO; WANG, ANLAI; KONG, LING QUAN
To: INCYTE CORPORATION
Reel/Frame 026467/0672 →
Assignment of Assignor's Interest
Mar 5, 2012
From: RODGERS, JAMES D.; ZHU, WENYU; GLENN, JOSEPH
To: INCYTE CORPORATION
Reel/Frame 027803/0195 →
Assignment of Assignor's Interest
Mar 14, 2012
From: RODGERS, JAMES D.; SHEPARD, STACEY; ZHU, WENYU; SHAO, LIXIN
To: INCYTE CORPORATION
Reel/Frame 027862/0297 →
Assignment of Assignor's Interest
Oct 19, 2012
From: RODGERS, JAMES D.; ARVANITIS, ARGYRIOS G.
To: INCYTE CORPORATION
Reel/Frame 029158/0027 →
Assignment of Assignor's Interest
Oct 19, 2012
From: ZHOU, JIACHENG; WU, YONGZHONG; LIU, PINGLI; CAO, GANFENG
To: INCYTE CORPORATION
Reel/Frame 029158/0001 →
Assignment of Assignor's Interest
Oct 19, 2012
From: YAO, WENQING; BURNS, DAVID M.; ZHUO, JINCONG
To: INCYTE CORPORATION
Reel/Frame 029157/0967 →
Assignment of Assignor's Interest
Oct 18, 2013
From: RODGERS, JAMES D.; SHEPARD, STACEY; ZHU, WENYU; SHAO, LIXIN
To: INCYTE CORPORATION
Reel/Frame 031435/0982 →
Assignment of Assignor's Interest
Feb 21, 2014
From: YAO, WENQING; BURNS, DAVID M.; ZHUO, JINCONG
To: INCYTE CORPORATION
Reel/Frame 032270/0191 →
Assignment of Assignor's Interest
Mar 5, 2014
From: LIU, PINGLI; WANG, DENGJIN; WU, YONGZHONG; CAO, GANFENG
To: INCYTE CORPORATION
Reel/Frame 032356/0744 →
Assignment of Assignor's Interest
Apr 11, 2014
From: RODGERS, JAMES D.; SHEPARD, STACEY; ARVANITIS, ARGYRIOS G.; WANG, HAISHENG
To: INCYTE CORPORATION
Reel/Frame 032659/0062 →
Assignment of Assignor's Interest
May 6, 2014
From: LIU, PINGLI; WANG, DENGJIN; WU, YONGZHONG; CAO, GANFENG
To: INCYTE CORPORATION
Reel/Frame 032828/0001 →
Assignment of Assignor's Interest
Jul 16, 2014
From: LI, YUN-LONG; ZHU, WENYU; MEI, SONG; GLENN, JOSEPH
To: INCYTE CORPORATION
Reel/Frame 033323/0174 →
Assignment of Assignor's Interest
Jul 28, 2014
From: HUANG, TAISHENG; XUE, CHU-BIAO; WANG, ANLAI; KONG, LINGQUAN
To: INCYTE CORPORATION
Reel/Frame 033402/0325 →